To assess the diagnostic performance of FDG-PET/CT for patients with suspected pulmonary sarcoidosis and determine its correlation with specific clinically relevant biomarkers, such as lung function metrics.
Key Findings:
FDG-PET/CT is sensitive in detecting pulmonary sarcoidosis, often identifying inflammation before morphological changes.
Correlation between FDG-PET/CT findings and lung function metrics was evaluated, highlighting its potential prognostic value, particularly in assessing treatment response.
Interpretation:
FDG-PET/CT may enhance the diagnostic accuracy for pulmonary sarcoidosis and provide insights into disease activity and treatment response.
Limitations:
Variability in study designs and populations may affect the generalizability of findings, particularly in terms of diagnostic accuracy.
Lack of standardized diagnostic criteria for sarcoidosis complicates comparisons across studies, potentially leading to inconsistent results.
Conclusion:
FDG-PET/CT shows promise as a diagnostic and prognostic tool in pulmonary sarcoidosis, warranting further research to establish standardized protocols for its use.
